299926-06-0Relevant articles and documents
Merging Natural Products: Muraymycin–Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents
Niro, Giuliana,Weck, Stefanie C.,Ducho, Christian
, p. 16875 - 16887 (2020/11/30)
To overcome bacterial resistances, the need for novel antimicrobial agents is urgent. The class of so-called nucleoside antibiotics furnishes promising candidates for the development of new antibiotics, as these compounds block a clinically unexploited bacterial target: the integral membrane protein MraY, a key enzyme in cell wall (peptidoglycan) biosynthesis. Nucleoside antibiotics exhibit remarkable structural diversity besides their uridine-derived core motifs. Some sub-classes also show specific selectivities towards different Gram-positive and Gram-negative bacteria, which are poorly understood so far. Herein, the synthesis of a novel hybrid structure is reported, derived from the 5′-defunctionalized uridine core moiety of muraymycins and the peptide chain of sansanmycin B, as a new scaffold for the development of antimicrobial agents. The reported muraymycin–sansanmycin hybrid scaffold showed nanomolar activity against the bacterial target enzyme MraY, but displayed no significant antibacterial activity against S. aureus, E. coli, and P. aeruginosa.
Synthesis of (S,S)- and (R,R)- 2-amino-3-methylaminobutanoic acid (AMBA)
Hennings,Williams
, p. 1310 - 1314 (2007/10/03)
The synthesis and characterization of (S, S)- and (R, R)-2-amino-3-methylaminobutanoic acid starting from tert-butyl crotonate is described.
